Effect of reaction conditions on preparations of Rhenium-188 hydroxyethylidene diphosphonate complexes

被引:36
作者
Lin, WY
Hsieh, JF
Lin, CP
Hsieh, BT
Ting, G
Wang, SJ
Knapp, FF
机构
[1] Taichung Vet Gen Hosp, Dept Nucl Med, Taichung 40704, Taiwan
[2] Chi Mei Fdn Hosp, Tainan, Taiwan
[3] Natl Tsing Hua Univ, Dept Nucl Sci, Hsinchu, Taiwan
[4] Inst Nucl Energy Res, Lungtan 32500, Taiwan
[5] Oak Ridge Natl Lab, Nucl Med Grp, Oak Ridge, TN USA
关键词
rhenium-186; Re-188HEDP complexes; carrier;
D O I
10.1016/S0969-8051(99)00007-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Rhenium-186 (Re-186) hydroxyethylidene diphosphonate (HEDP) has been shown to localize in metastatic foci within bone in a manner similar to Tc-99m bone seeking agents. Usually, in the preparation of diagnostic Tc-99m radiopharmaceuticals, the concentration of Tc is at trace level (10(-8) M). However, large amounts of carrier are included in the preparation of Re-186 radiopharmaceuticals (10(-4) M), which may significantly affect the preparation of Re-HEDP. In this study, Re-188 was used as an Re tracer. The effects of pH and concentrations of Re carrier on the preparation of Re-HEDP were investigated. Re-188-Sn-HEDP was prepared by reconstitution of a kit of lyophilized HEDP mixture, and tin chloride with a radioactive solution of perrhenate in saline. The total concentration of Re present in this work ranged from 10(-8) to 10(-3) M. The results showed that high labeling efficiency was obtained for each preparation, Although the chemical behaviors of the Re-188 HEDP complexes, with and without carrier, were similar, the biodistribution patterns of carrier free Re-188 HEDP in rats were found to differ from the biodistribution patterns of carrier-added Re-188 HEDP. NUCL MED BIOL 26;4:455-459, 1999. (C) 1999 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:455 / 459
页数:5
相关论文
共 18 条
[1]   DOSE-ESCALATION STUDY OF RE-186 HYDROXYETHYLIDENE DIPHOSPHONATE IN PATIENTS WITH METASTATIC PROSTATE-CANCER [J].
DEKLERK, JMH ;
ZONNENBERG, BA ;
SCHIP, ADV ;
VANDIJK, A ;
HAN, SH ;
QUIRIJNEN, JMSP ;
BLIJHAM, GH ;
VANRIJK, PP .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1994, 21 (10) :1114-1120
[2]  
GRIFFITHS GL, 1991, CANCER RES, V51, P4594
[3]  
GRIFFITHS GL, 1992, RADIOACT RADIOCHEM, V3, P33
[4]   Ascorbic acid saline eluant increases Re-188 yields after ''wet'' storage of W-188/Re-188 generators [J].
Hsieh, BT ;
Callahan, AP ;
Beets, AL ;
Ting, G ;
Knapp, FF .
APPLIED RADIATION AND ISOTOPES, 1996, 47 (01) :23-26
[5]   EVALUATION OF PHOSPHORUS 32 FOR INTRACTABLE PAIN SECONDARY TO PROSTATIC CARCINOMA METASTASES [J].
JOSHI, DP ;
SEERY, WH ;
GOLDBERG, LG ;
GOLDMAN, L .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1965, 193 (07) :621-&
[6]  
KASI L P, 1992, Journal of Nuclear Medicine, V33, P992
[7]   SM-153 EDTMP AND RE-186-HEDP AS BONE THERAPEUTIC RADIOPHARMACEUTICALS [J].
KETRING, AR .
NUCLEAR MEDICINE AND BIOLOGY, 1987, 14 (03) :223-232
[8]  
KIM SI, 1988, ANTICANCER RES, V8, P681
[9]  
KNAPP FF, 1994, EUR J NUCL MED, V21, P1151
[10]   PROCESSING OF REACTOR-PRODUCED W-188 FOR FABRICATION OF CLINICAL-SCALE ALUMINA-BASED W-188/RE-188 GENERATORS [J].
KNAPP, FF ;
CALLAHAN, AP ;
BEETS, AL ;
MIRZADEH, S ;
HSIEH, BT .
APPLIED RADIATION AND ISOTOPES, 1994, 45 (12) :1123-1128